GATX Corp. Senior Unsecured Notes Rated 'BBB' May 11

  • ID: 1827232
  • May 2011
  • Standard & Poors
1 of 3

NEW YORK (Standard & Poor's) May 24, 2011--Standard & Poor's Ratings Services said today that it has assigned its 'BBB' rating to GATX Corp.'s senior unsecured notes. The issue is a drawdown under a Rule 415 shelf registration. The company will use the proceeds to repay commercial paper and other outstanding debt and for general corporate purposes, including working capital and capital spending. The ratings on GATX reflect its strong market position in its major business--tank car leasing; relatively consistent tank car lease demand, even in periods of economic weakness; and long-term leases and contracts that produce relatively stable cash flow. The ratings also incorporate the company's high debt leverage relative to its peers and the less-predictable revenues and earnings...

Companies mentioned in this report are:
- GATX Corp.

Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

- GATX Corp.

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.